Cargando…

Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists

PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international...

Descripción completa

Detalles Bibliográficos
Autores principales: Fouzdar Jain, Samiksha, Song, Helen H, Al-Holou, Shaza N, Morgan, Linda A, Suh, Donny W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978463/
https://www.ncbi.nlm.nih.gov/pubmed/29881255
http://dx.doi.org/10.2147/OPTH.S161504
_version_ 1783327532255281152
author Fouzdar Jain, Samiksha
Song, Helen H
Al-Holou, Shaza N
Morgan, Linda A
Suh, Donny W
author_facet Fouzdar Jain, Samiksha
Song, Helen H
Al-Holou, Shaza N
Morgan, Linda A
Suh, Donny W
author_sort Fouzdar Jain, Samiksha
collection PubMed
description PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. RESULTS: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. CONCLUSION: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug.
format Online
Article
Text
id pubmed-5978463
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-59784632018-06-07 Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists Fouzdar Jain, Samiksha Song, Helen H Al-Holou, Shaza N Morgan, Linda A Suh, Donny W Clin Ophthalmol Original Research PURPOSE: The treatment of retinopathy of prematurity (ROP) is not standardized and can vary significantly between providers. This study aims to determine preferred practices in treating ROP by globally surveying pediatric ophthalmologists. METHODS: Between January and February 2017, an international pediatric ophthalmology interest group was invited to complete an anonymous survey of 18 questions. The main objectives were to determine the preferred first line of treatment for ROP, the preferred dosage of intravitreal bevacizumab (IVB) used, and the outcome and possible complications following bevacizumab injection. RESULTS: Out of 101 pediatric ophthalmologists, 72 (71.8%) stated that they had direct involvement in the treatment of ROP. When presented with type 1 ROP which requires treatment, 69 ophthalmologists (68.3%) stated that they prefer laser treatment over bevacizumab, and 33 ophthalmologists (32.7%) stated they would recommend bevacizumab as a first choice. Ninety-three ophthalmologists (92.1%) reported the success of 1 laser treatment between 75% and 100%, and 35 ophthalmologists (34.7%) perceive bevacizumab to be 75%–100% successful. Half dose of adult-prescribed bevacizumab at 0.625 mg/0.05 mL was preferred by 47 of the ophthalmologists (46.5%). No cases of endophthalmitis were reported with intravitreal injection. CONCLUSION: Laser photoablation remains the preferred mode of treatment for ROP among surveyed ophthalmologists across the world. Though bevacizumab is currently being used, this form of treatment is not as common, primarily due to the unknown safety profile and potential long-term ramifications of the drug. Dove Medical Press 2018-05-25 /pmc/articles/PMC5978463/ /pubmed/29881255 http://dx.doi.org/10.2147/OPTH.S161504 Text en © 2018 Fouzdar Jain et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Fouzdar Jain, Samiksha
Song, Helen H
Al-Holou, Shaza N
Morgan, Linda A
Suh, Donny W
Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_full Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_fullStr Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_full_unstemmed Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_short Retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
title_sort retinopathy of prematurity: preferred practice patterns among pediatric ophthalmologists
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5978463/
https://www.ncbi.nlm.nih.gov/pubmed/29881255
http://dx.doi.org/10.2147/OPTH.S161504
work_keys_str_mv AT fouzdarjainsamiksha retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists
AT songhelenh retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists
AT alholoushazan retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists
AT morganlindaa retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists
AT suhdonnyw retinopathyofprematuritypreferredpracticepatternsamongpediatricophthalmologists